Abstract:Preimplantation genetic testing for aneuploidies (PGT-A) and PGT for monogenic disorders (PGT-M) have currently been used widely, aiming to improve IVF outcomes. Although with many years of unsatisfactory results, PGT-A has been revived because new technologies have been adopted, such as platforms to examine all 24 types of chromosomes in blastocysts. This report compiles current knowledge regarding the available PGT platforms, including quantitative PCR, array CGH, and next-generation sequencing. The diagnostic capabilities of are compared and respective advantages/disadvantages outlined. We also address the limitations of current technologies, such as assignment of embryos with balanced translocation. We also discuss the emerging novel PGT technologies that likely will change our future practice, such as non-invasive PGT examining spent culture medium. Current literature suggest that most platforms can effectively reach concordant results regarding whole-chromosome ploidy status of all 24 types of chromosomes. However, different platforms have different resolutions and experimental complexities; leading to different turnaround time, throughput and differential capabilities of detecting mosaicism, segmental mutations, unbalanced translocations, concurrent PGT-A and PGT-M etc. Based on these information, IVF staff can more appropriately interpret PGT data and counsel patients, and select suitable platforms to meet personalized needs. The present report also concisely discusses some crucial clinical outcomes by PGT, which can clarify the role of applying PGT in daily IVF programs. Finally the up-to-date information about the novel use of current technologies and the newly emerging technologies will also help identify the focus areas for the design of new platforms for PGT in the future.

Application of preimplantation genetic testing technique in in vitro fertilization and embryo transfer

Application of the High-throughput Technologies in Preimplantation Genetic Diagnosis

Research Progress and Challenges of Preimplantation Genetic Testing for Polygenic Diseases.

Current Status and New Progress of the Preimplantation Genetic Testing

Noninvasive preimplantation genetic testing in assisted reproductive technology: current state and future perspectives

Application and Challenge of Preimplantation Genetic Testing in Reproductive Medicine

Recent Advances of Preimplantation Genetic Diagnosis

Clinical application and reflection of molecular biology technology in the tertiary prevention of birth defects

Advances in Preimplantation Genetic Diagnosis/screening

Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers.

Preimplantation genetic testing in the current era, a review

Current Status and Recent Advances in Preimplantation Genetic Testing for Structural Rearrangements

The current clinical applications of preimplantation genetic testing (PGT): acknowledging the limitations of biology and technology

An overview of the current and emerging platforms for preimplantation genetic testing for aneuploidies (PGT-A) in in vitro fertilization programs

Application of Preimplantation Genetic Diagnosis in Eugenics

A Novel Preimplantation Genetic Testing Strategy for a Subtelomeric Genetic Disorder: A Case Study

[Preimplantation Genetic Diagnosis: Two Successful Cases]

Role of preimplantation genetic testing for aneuploidies in male factor infertility

Identification of Embryonic Chromosomal Abnormality Using FISH-based Preimplantaion Genetic Diagnosis

PREIMPLANTATION GENETIC TESTING: Single-cell technologies at the forefront of PGT and embryo research

Preimplantation genetic testing: A remarkable history of pioneering, technical challenges, innovations, and ethical considerations